Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-032322
Filing Date
2022-05-26
Accepted
2022-05-26 18:21:21
Documents
1
Period of Report
2022-05-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6596
  Complete submission text file 0001209191-22-032322.txt   8020
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Issuer) CIK: 0001457612 (see all company filings)

EIN.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2855 SAND HILL ROAD MENLO PARK CA 94025
Business Address
Chang Carmen (Reporting) CIK: 0001746342 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36289 | Film No.: 22971913